DOI QR코드

DOI QR Code

Stress Accelerates Depressive-Like Behaviors through Increase of Notch2 Expression in N141I Mutation Presenilin-2 Transgenic Mice

  • Seung Sik Yoo (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Sun Mi Gu (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Kyung Tak Nam (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Jeong Soon Choi (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Yong Sun Lee (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • In Jun Yeo (Healthcare Convergence Educational Group for Infectious Disease Management, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University) ;
  • Ji Eun Yu (Department of Pharmacy, College of Pharmacy, Mokpo National University) ;
  • Sanghyeon Kim (Stanley Brain Research Laboratory, Stanley Medical Research Institute, 9800 Medical Center Drive) ;
  • Dong Won Lee (National Institute of Food and Drug Safety Evaluation) ;
  • Hyeon Joo Ham (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Ju Young Chang (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Jaesuk Yun (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Dong Ju Son (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Sang-Bae Han (College of Pharmacy and Medical Research Center, Chungbuk National University) ;
  • Jin Tae, Hong (College of Pharmacy and Medical Research Center, Chungbuk National University)
  • Received : 2025.12.01
  • Accepted : 2026.03.16
  • Published : 2026.05.01

Abstract

Alzheimer's disease (AD) is characterized by progressive cognitive deterioration and significant depression. However, the mechanisms linking depression to AD pathology remain unclear. Here, we investigated whether Notch2 signaling mediates depression-like behaviors in presenilin-2 (PS2) N141I mutant mice, an early-onset AD model. PS2 wild-type (WT) and mutant (MT) mice aged 12-15 months were subjected to unpredictable chronic mild stress (UCMS) for 4 weeks, followed by sucrose preference, tail-hanging, and forced swimming tests. Behavioral assessments showed that UCMS exacerbated anhedonia and immobility only in PS2 MT mice. Molecular analysis revealed concomitant increases in plasma corticosterone, hippocampal γ-secretase activity, and Notch2 expression, and elevated total and phosphorylated glucocorticoid receptor levels in PS2 MT-UCMS mice. Gene expression profiling of human hippocampal datasets confirmed upregulation of NOTCH2 in Alzheimer's disease and depression. Pharmacological inhibition of γ-secretase and Notch signaling with DAPT normalizes depressive behavior, reduces corticosterone release, attenuates GR phosphorylation, and inhibits Notch2 signaling in PS2 MT mice. These findings identify Notch2 as a pivotal mediator linking chronic stress to molecular changes associated with depression and AD, and suggest that targeting Notch2 signaling may provide therapeutic benefits for comorbid mood and neurodegenerative disorders.

Keywords

Acknowledgement

This work was financially supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. RS-2025-02273102), the Bio&Medical Technology Development Program of the NRF funded by the Korea government (MSIT) (No. RS-2024-00440787), and Basic Science Research Program through the NRF funded by the Ministry of Education (RS-2024-00460411).

References

  1. Anacker, C., Zunszain, P. A., Carvalho, L. A. and Pariante, C. M. (2011) The glucocorticoid receptor: pivot of depression and of antidepres sant treatment? Psychoneuroendocrinology 36, 415-425. https://doi.org/10.1016/j.psyneuen.2010.03.007
  2. Aznar, S. and Knudsen, G. M. (2011) Depression and Alzheimer's dis ease: is stress the initiating factor in a common neuropathological cascade? J. Alzheimers Dis. 23, 177-193. https://doi.org/10.3233/JAD-2010-100390
  3. Bei, E., Salpeas, V., Pappa, D., Anagnostara, C., Alevizos, V. and Moutsatsou, P. (2009) Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lympho cytes of euthymic, depressed and manic bipolar patients. Psycho neuroendocrinology 34, 1162-1175. https://doi.org/10.1016/j.psyneuen.2009.03.002
  4. Belmaker, R. H. and Agam, G. (2008) Major depressive disorder. N. Engl. J. Med. 358, 55-68. https://doi.org/10.1056/NEJMra073096
  5. Berezovska, O., Xia, M. and Hyman, B. (1998) Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57, 738-745. https://doi.org/10.1097/00005072-199808000-00003
  6. Bittner, T., Fuhrmann, M., Burgold, S., Jung, C. K., Volbracht, C., Stein er, H., Mitteregger, G., Kretzschmar, H. A., Haass, C. and Herms, J. (2009) γ-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J. Neurosci. 29, 10405-10409. https://doi.org/10.1523/JNEUROSCI.2288-09.2009
  7. Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., De Vito, F., Caioli, S., Guadalupi, L., Bullitta, S., Vanni, V., Bal letta, S., Sanna, K., Buttari, F., Stampanoni Bassi, M., Centonze, D. and Mandolesi, G. (2020) Inflammation-associated synaptic altera tions as shared threads in depression and multiple sclerosis. Front. Cell. Neurosci. 14, 169.
  8. Burke, A. D., Goldfarb, D., Bollam, P. and Khokher, S. (2019) Diag nosing and treating depression in patients with Alzheimer's dis ease. Neurol. Ther. 8, 325-350. https://doi.org/10.1007/s40120-019-00148-5
  9. Burstein, O. and Doron, R. (2018) The unpredictable chronic mild stress protocol for inducing anhedonia in mice. J. Vis. Exp. 140, e58184.
  10. Butterfield, D. A., Reed, T., Newman, S. F. and Sultana, R. (2007) Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 43, 658-677. https://doi.org/10.1016/j.freeradbiomed.2007.05.037
  11. Capilla-López, M. D., Deprada, A., Andrade-Talavera, Y., Martínez Gallego, I., Coatl-Cuaya, H., Sotillo, P., Rodríguez-Alvarez, J., Rodríguez-Moreno, A., Parra-Damas, A. and Saura, C. A. (2025) Synaptic vulnerability to amyloid-β and tau pathologies differential ly disrupts emotional and memory neural circuits. Mol. Psychiatry 30, 2966-2979. https://doi.org/10.1038/s41380-025-02901-9
  12. Caraci, F., Copani, A., Nicoletti, F. and Drago, F. (2010) Depression and Alzheimer's disease: neurobiological links and common phar macological targets. Eur. J. Pharmacol. 626, 64-71. https://doi.org/10.1016/j.ejphar.2009.10.022
  13. Charney, D. S. and Manji, H. K. (2004) Life stress, genes, and depres sion: multiple pathways lead to increased risk and new opportuni ties for intervention. Sci. STKE 2004, re5. https://doi.org/10.1126/stke.2252004re5
  14. Chojnowska, S., Ptaszyńska-Sarosiek, I., Kępka, A., Knaś, M. and Waszkiewicz, N. (2021) Salivary biomarkers of stress, anxiety and depression. J. Clin. Med. 10, 517.
  15. Cowen, P. (2010) Not fade away: the HPA axis and depression. Psy chological medicine. 40, 1-4. https://doi.org/10.1017/S0033291709005558
  16. De Kloet, E. R., Joëls, M. and Holsboer, F. (2005) Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475. https://doi.org/10.1038/nrn1683
  17. Delabio, R., Rasmussen, L., Mizumoto, I., Viani, G.-A., Chen, E., Vil lares, J., Costa, I.-B., Turecki, G., Linde, S. A. and Smith, M. C. (2014) PSEN1 and PSEN2 gene expression in Alzheimer's dis ease brain: a new approach. J. Alzheimers Dis. 42, 757-760. https://doi.org/10.3233/JAD-140033
  18. Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., de Saint Andrieu, P., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E., Hol sztynska, E. J., Hu, K. L., Johnson-Wood, K. L., Kennedy, S. L., Kholodenko, D., Knops, J. E., Latimer, L. H., Lee, M., Liao, Z., Li eberburg, I. M., Motter, R. N., Mutter, L. C., Nietz, J., Quinn, K. P., Sacchi, K. L., Seubert, P. A., Shopp, G. M., Thorsett, E. D., Tung, J. S., Wu, J., Yang, S., Yin, C. T., Schenk, D. B., May, P. C., Altstiel, L. D., Bender, M. H., Boggs, L. N., Britton, T. C., Clemens, J. C., Czilli, D. L., Dieckman-McGinty, D. K., Droste, J. J., Fuson, K. S., Gitter, B. D., Hyslop, P. A., Johnstone, E. M., Li, W. Y., Little, S. P., Mabry, T. E., Miller, F. D. and Audia, J. E. (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 76, 173-181. https://doi.org/10.1046/j.1471-4159.2001.00012.x
  19. Farooq, R. K., Isingrini, E., Tanti, A., Le Guisquet, A.-M., Arlicot, N., Minier, F., Leman, S., Chalon, S., Belzung, C. and Camus, V. (2012) Is unpredictable chronic mild stress (UCMS) a reliable mod el to study depression-induced neuroinflammation? Behav. Brain Res. 231, 130-137. https://doi.org/10.1016/j.bbr.2012.03.020
  20. Fava, M. and Kendler, K. S. (2000) Major depressive disorder. Neuron 28, 335-341. https://doi.org/10.1016/S0896-6273(00)00112-4
  21. Fee, C., Prevot, T., Misquitta, K., Banasr, M. and Sibille, E. (2020) Chronic stress-induced behaviors correlate with exacerbated acute stress-induced cingulate cortex and ventral hippocampus activa tion. Neuroscience 440, 113-129. https://doi.org/10.1016/j.neuroscience.2020.05.034
  22. Frisbee, J. C., Brooks, S. D., Stanley, S. C. and d'Audiffret, A. C. (2015) An unpredictable chronic mild stress protocol for instigat ing depressive symptoms, behavioral changes and negative health outcomes in rodents. J. Vis. Exp. 106, e53109.
  23. Frodl, T. and O'Keane, V. (2013) How does the brain deal with cumula tive stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol. Dis. 52, 24-37. https://doi.org/10.1016/j.nbd.2012.03.012
  24. Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S. and Gil-Mohapel, J. (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci. Biobehav. Rev. 102, 56-84. https://doi.org/10.1016/j.neubiorev.2019.04.002
  25. Gold, P. W. (2015) The organization of the stress system and its dys regulation in depressive illness. Mol. Psychiatry 20, 32-47. https://doi.org/10.1038/mp.2014.163
  26. Goodyer, I. M., Herbert, J., Tamplin, A. and Altham, P. (2000) Recent life events, cortisol, dehydroepiandrosterone and the onset of ma jor depression in high-risk adolescents. Br. J. Psychiatry 177, 499-504. https://doi.org/10.1192/bjp.177.6.499
  27. Goosens, K. A. and Sapolsky, R. M. (2007) Stress and glucocorticoid contributions to normal and pathological aging. In Brain Aging, pp.305-322.
  28. Griffiths, J. and Grant, S. G. N. (2023) Synapse pathology in Alzheim er's disease. Semin. Cell Dev. Biol. 139, 13-23. https://doi.org/10.1016/j.semcdb.2022.05.028
  29. Gu, S. M., Lee, H. P., Ham, Y. W., Son, D. J., Kim, H. Y., Oh, K. W., Han, S. B., Yun, J. and Hong, J. T. (2018) Piperlongumine improves lipopolysaccharide-induced amyloidogenesis by suppressing NF kappaB pathway. Neuromolecular Med. 20, 312-327. https://doi.org/10.1007/s12017-018-8495-9
  30. Guilliams, T. G. and Edwards, L. (2010) Chronic stress and the HPA axis. The Standard 9, 1-12.
  31. Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., Mas ters, C. L., Cho, M., Lannfelt, L., Cummings, J. L. and Vergallo, A. (2021) The Amyloid-β Pathway in Alzheimer's Disease. Mol. Psy chiatry 26, 5481-5503. https://doi.org/10.1038/s41380-021-01249-0
  32. Harris, T., Borsanyi, S., Messari, S., Stanford, K., Cleary, S., Shiers, H., Brown, G. and Herbert, J. (2000) Morning cortisol as a risk fac tor for subsequent major depressive disorder in adult women. Br. J. Psychiatry 177, 505-510. https://doi.org/10.1192/bjp.177.6.505
  33. Heim, C. and Nemeroff, C. B. (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49, 1023-1039. https://doi.org/10.1016/S0006-3223(01)01157-X
  34. Henrique, D. and Schweisguth, F. (2019) Mechanisms of Notch signal ing: a simple logic deployed in time and space. Development 146, dev172148.
  35. Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Ma kinson, R., Scheimann, J. and Myers, B. (2016) Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr. Physiol. 6, 603-621. https://doi.org/10.1002/cph4.v6.2
  36. Hwang, C. J., Park, M. H., Choi, M. K., Choi, J. S., Oh, K. W., Hwang, D. Y., Han, S. B. and Hong, J. T. (2016) Acceleration of amyloido genesis and memory impairment by estrogen deficiency through NF-κB dependent beta-secretase activation in presenilin 2 mutant mice. Brain Behav. Immun. 53, 113-122. https://doi.org/10.1016/j.bbi.2015.11.013
  37. Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J. and Min, S. H. (2002) Altera tions in behavior, amyloid p-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 16, 805-813. https://doi.org/10.1096/fsb2.v16.8
  38. Imbimbo, B. P. (2008) Therapeutic potential of γ-secretase inhibitors and modulators. Curr. Top. Med. Chem. 8, 54-61. https://doi.org/10.2174/156802608783334015
  39. Ismaili, N. and Garabedian, M. J. (2004) Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 1024, 86-101. https://doi.org/10.1196/annals.1321.007
  40. Kapoor, A. and Nation, D. A. (2021) Role of Notch signaling in neu rovascular aging and Alzheimer's disease. Semin. Cell Dev. Biol. 116, 90-97. https://doi.org/10.1016/j.semcdb.2020.12.011
  41. Khairova, R. A., Machado-Vieira, R., Du, J. and Manji, H. K. (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int. J. Neuropsychopharma col. 12, 561-578. https://doi.org/10.1017/S1461145709009924
  42. Kino, T. (2015) Stress, glucocorticoid hormones, and hippocampal neural progenitor cells: implications to mood disorders. Front. Physiol. 6, 230. https://doi.org/10.3389/fphys.2015.00230
  43. Kopan, R. and Goate, A. (2000) A common enzyme connects Notch signaling and Alzheimer's disease. Genes Dev. 14, 2799-2806. https://doi.org/10.1101/gad.836900
  44. Krishnan, V. and Nestler, E. J. (2008) The molecular neurobiology of depression. Nature 455, 894-902. https://doi.org/10.1038/nature07455
  45. Lanoiselée, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A. and Martinaud, O. (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of famil ial and sporadic cases. PLoS Med. 14, e1002270. https://doi.org/10.1371/journal.pmed.1002270
  46. Lanz, T. A., Himes, C. S., Pallante, G., Adams, L., Yamazaki, S., Amore, B. and Merchant, K. M. (2003a) The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t butyl ester reduces A beta levels in vivo in plasma and cerebrospi nal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice. J. Pharmacol. Exp. Ther. 305, 864-871. https://doi.org/10.1124/jpet.102.048280
  47. Lanz, T. A., Himes, C. S., Pallante, G., Adams, L., Yamazaki, S., Amore, B. and Merchant, K. M. (2003b) The γ-secretase inhibitor N-[N-(3, 5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl es ter reduces Aβ levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice. J. Pharmacol. Exp. Ther. 305, 864-871. https://doi.org/10.1124/jpet.102.048280
  48. Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W. and Hong, J. T. (2008) Neuro-inflammation induced by lipopoly saccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflamm. 5, 1-14. https://doi.org/10.1186/1742-2094-5-37
  49. Lee, S. Y., Hwang, D. Y., Kim, Y. K., Lee, J. W., Shin, I. C., Oh, K. W., Lee, M. K., Lim, J. S., Yoon, D. Y. and Hwang, S. J. (2006) PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine recep tor-mediated calcium release. FASEB J. 20, 151-153.
  50. Lee, Y. J., Choi, I. S., Park, M. H., Lee, Y. M., Song, J. K., Kim, Y. H., Kim, K. H., Hwang, D. Y., Jeong, J. H. and Yun, Y. P. (2011) 4-O Methylhonokiol attenuates memory impairment in presenilin 2 mu tant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic. Biol. Med. 50, 66-77. https://doi.org/10.1016/j.freeradbiomed.2010.10.698
  51. Lee, Y. J., Kim, J. E., Hwang, I. S., Kwak, M. H., Lee, J. H., Jung, Y. J., An, B. S., Kwon, H. S., Kim, B. C. and Kim, S. J. (2013) Alzheimer's phenotypes induced by overexpression of human presenilin 2 mu tant proteins stimulate significant changes in key factors of glucose metabolism. Mol. Med. Rep. 7, 1571-1578. https://doi.org/10.3892/mmr.2013.1404
  52. Levenson, R. W., Sturm, V. E. and Haase, C. M. (2014) Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology. Annu. Rev. Clin. Psychol. 10, 581-606. https://doi.org/10.1146/clinpsy.2014.10.issue-1
  53. Levinson, D. F. (2006) The genetics of depression: a review. Biol. Psy chiatry 60, 84-92. https://doi.org/10.1016/j.biopsych.2005.08.024
  54. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C. E., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guenette, S. Y., Galas, D., Nemens, E., Wijsman, E. M., Bird, T. D., Schellenberg, G. D. and Tanzi, R. E. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977. https://doi.org/10.1126/science.7638622
  55. Liang, J. W., Fang, Z. Y., Huang, Y., Liuyang, Z. Y., Zhang, X. L., Wang, J. L., Wei, H., Wang, J. Z., Wang, X. C., Zeng, J. and Liu, R. (2018) Application of weighted gene co-expression network analysis to explore the key genes in Alzheimer's disease. J. Alzheimers Dis. 65, 1353-1364. https://doi.org/10.3233/JAD-180400
  56. Liao, J., Zeng, G., Fang, W., Huang, W., Dai, X., Ye, Q., Zhang, J. and Chen, X. (2021) Increased Notch2/NF-κB signaling may mediate the depression susceptibility: evidence from chronic social defeat stress mice and WKY rats. Physiol. Behav. 228, 113197. https://doi.org/10.1016/j.physbeh.2020.113197
  57. Lindsay, J., Laurin, D., Verreault, R., Hébert, R., Helliwell, B., Hill, G. B. and McDowell, I. (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Ag ing. Am. J. Epidemiol. 156, 445-453. https://doi.org/10.1093/aje/kwf074
  58. Liu, M. Y., Yin, C. Y., Zhu, L. J., Zhu, X. H., Xu, C., Luo, C. X., Chen, H., Zhu, D. Y. and Zhou, Q. G. (2018) Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat. Protoc. 13, 1686-1698. https://doi.org/10.1038/s41596-018-0011-z
  59. Martin, A. P., Bradshaw, G. A., Eisert, R. J., Egan, E. D., Tveriakhina, L., Rogers, J. M., Dates, A. N., Scanavachi, G., Aster, J. C., Kirch hausen, T., Kalocsay, M. and Blacklow, S. C. (2023) A spatiotempo ral Notch interaction map from plasma membrane to nucleus. Sci. Signal. 16, eadg6474.
  60. Milligan Armstrong, A., Porter, T., Quek, H., White, A., Haynes, J., Jackaman, C., Villemagne, V., Munyard, K., Laws, S. M., Verdile, G. and Groth, D. (2021) Chronic stress and Alzheimer's disease: the interplay between the hypothalamic-pituitary-adrenal axis, ge netics and microglia. Biol. Rev. Camb. Philos. Soc. 96, 2209-2228. https://doi.org/10.1111/brv.v96.5
  61. Mineur, Y. S., Prasol, D. J., Belzung, C. and Crusio, W. E. (2003) Ago nistic behavior and unpredictable chronic mild stress in mice. Be hav. Genet. 33, 513-519.
  62. Netzer, W. J., Powell, C., Nong, Y., Blundell, J., Wong, L., Duff, K., Flajolet, M. and Greengard, P. (2010) Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse mod el. PLoS One 5, e10943.
  63. Nisbet, R. M. and Götz, J. (2018) Amyloid-β and tau in Alzheimer's disease: Novel pathomechanisms and non-pharmacological treat ment strategies. J. Alzheimers Dis. 64, S517-S527. https://doi.org/10.3233/JAD-179907
  64. Nollet, M. (2021) Models of depression: unpredictable chronic mild stress in mice. Curr. Protoc. 1, e208. https://doi.org/10.1002/cpz1.v1.8
  65. Pariante, C. M. and Lightman, S. L. (2008) The HPA axis in major de pression: classical theories and new developments. Trends Neu rosci. 31, 464-468. https://doi.org/10.1016/j.tins.2008.06.006
  66. Pariante, C. M. and Miller, A. H. (2001) Glucocorticoid receptors in ma jor depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49, 391-404. https://doi.org/10.1016/S0006-3223(00)01088-X
  67. Park, M. H., Choi, D. Y., Jin, H. W., Yoo, H. S., Han, J.-Y., Oh, K.-W., Han, S. B., Hwang, D. Y. and Hong, J. T. (2012) Mutant presenilin 2 increases β-secretase activity through reactive oxygen species dependent activation of extracellular signal–regulated kinase. J. Neuropathol. Exp. Neurol. 71, 130-139. https://doi.org/10.1097/NEN.0b013e3182432967
  68. Price, D. L., Sisodia, S. S. and Gandy, S. E. (1995) Amyloid beta amy loidosis in Alzheimer's disease. Curr. Opin. Neurol. 8, 268-274. https://doi.org/10.1097/00019052-199508000-00004
  69. Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W., van Rossum, E. F. and Feelders, R. A. (2013) Glucocorticoid sensitivity in health and disease. Nat. Rev. Endocrinol. 9, 670-686. https://doi.org/10.1038/nrendo.2013.183
  70. Rogatsky, I., Waase, C. L. and Garabedian, M. J. (1998) Phosphoryla tion and inhibition of rat glucocorticoid receptor transcriptional ac tivation by glycogen synthase kinase-3 (GSK-3): species-specific differences between human and rat glucocorticoid receptor signal ing as revealed through GSK-3 phosphorylation. J. Biol. Chem. 273, 14315-14321. https://doi.org/10.1074/jbc.273.23.14315
  71. Ruan, C. S., Zhou, F. H., He, Z.-Y., Wang, S., Yang, C.-R., Shen, Y.-J., Guo, Y., Zhao, H., Chen, L. and Liu, D. (2015) Mice deficient for wild-type p53-induced phosphatase 1 display elevated anxiety-and depression-like behaviors. Neuroscience 293, 12-22. https://doi.org/10.1016/j.neuroscience.2015.02.037
  72. Sáiz-Vázquez, O., Gracia-García, P., Ubillos-Landa, S., Puente-Mar tínez, A., Casado-Yusta, S., Olaya, B. and Santabárbara, J. (2021) depression as a risk factor for alzheimer's disease: a systematic review of longitudinal meta-analyses. J. Clin. Med. 10, 1809.
  73. Sapolsky, R. M. (1986) Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J. Neurosci. 6, 2240-2244. https://doi.org/10.1523/JNEUROSCI.06-08-02240.1986
  74. Sharma, S., Chawla, S., Kumar, P., Ahmad, R. and Kumar Verma, P. (2024) The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bed side. Brain Res. 1843, 149123. https://doi.org/10.1016/j.brainres.2024.149123
  75. Singh-Manoux, A., Dugravot, A., Fournier, A., Abell, J., Ebmeier, K., Kivimäki, M. and Sabia, S. (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry 74, 712-718. https://doi.org/10.1001/jamapsychiatry.2017.0660
  76. Spires-Jones, T. L. and Hyman, B. T. (2014) The intersection of amy loid beta and tau at synapses in Alzheimer's disease. Neuron 82, 756-771. https://doi.org/10.1016/j.neuron.2014.05.004
  77. Sprinzak, D. and Blacklow, S. C. (2021) Biophysics of Notch signal ing. Annu. Rev. Biophys. 50, 157-189. https://doi.org/10.1146/biophys.2021.50.issue-1
  78. Steiner, H. (2008) The catalytic core of gamma-secretase: presenilin revisited. Curr. Alzheimer Res. 5, 147-157. https://doi.org/10.2174/156720508783954677
  79. Strekalova, T., Spanagel, R., Dolgov, O. and Bartsch, D. (2005) Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav. Pharmacol. 16, 171-180. https://doi.org/10.1097/00008877-200505000-00006
  80. Strekalova, T. and Steinbusch, H. W. (2010) Measuring behavior in mice with chronic stress depression paradigm. Prog. Neuro-Psy chopharmacol. Biol. Psychiatry 34, 348-361. https://doi.org/10.1016/j.pnpbp.2009.12.014
  81. Vito, P., Wolozin, B., Ganjei, J. K., Iwasaki, K., Lacaná, E. and D'Adamio, L. (1996) Requirement of the familial Alzheimer's dis ease gene PS2 for apoptosis: opposing effect of ALG-3. J. Biol. Chem. 271, 31025-31028. https://doi.org/10.1074/jbc.271.49.31025
  82. Wang, J.-J., Zhu, J.-D., Zhang, X.-H., Long, T.-T., Ge, G. and Yu, Y. (2019) Neuroprotective effect of Notch pathway inhibitor DAPT against focal cerebral ischemia/reperfusion 3 hours before model establishment. Neural Regen. Res. 14, 452.
  83. Willner, P. (2017) The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol. Stress 6, 78-93. https://doi.org/10.1016/j.ynstr.2016.08.002
  84. Wingo, T. S., Liu, Y., Gerasimov, E. S., Vattathil, S. M., Wynne, M. E., Liu, J., Lori, A., Faundez, V., Bennett, D. A., Seyfried, N. T., Levey, A. I. and Wingo, A. P. (2022) Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat. Commun. 13, 4314.
  85. Wolfe, M. S. (2012) γ-Secretase as a target for Alzheimer's dis ease. Adv. Pharmacol. 64, 127-153. https://doi.org/10.1016/B978-0-12-394816-8.00004-0
  86. Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J. K., Lacanà, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W. and D'Adamio, L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713. https://doi.org/10.1126/science.274.5293.1710
  87. Woo, H.-N., Park, J.-S., Gwon, A. R., Arumugam, T. V. and Jo, D.-G. (2009) Alzheimer's disease and Notch signaling. Biochem. Bio phys. Res. Commun. 390, 1093-1097. https://doi.org/10.1016/j.bbrc.2009.10.093
  88. Wu, X., Chen, B., Di, Z., Jiang, S., Xu, H., Shi, M., Hu, R., Sun, S., Song, Z., Liu, J., Ma, R. and Guo, Q. (2022) Involvement of kyn urenine pathway between inflammation and glutamate in the un derlying etiopathology of CUMS-induced depression mouse mod el. BMC Neurosci. 23, 62. https://doi.org/10.1186/s12868-022-00746-4
  89. Wuwongse, S., Cheng, S. S.-Y., Wong, G. T.-H., Hung, C. H.-L., Zhang, N. Q., Ho, Y.-S., Law, A. C.-K. and Chang, R. C.-C. (2013) Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease. Biochim. Biophys. Acta Mol. Basis Dis. 1832, 2245-2256. https://doi.org/10.1016/j.bbadis.2013.07.022
  90. Xu, B., Lang, L.-m., Li, S.-Z., Guo, J.-R., Wang, J.-F., Wang, D., Zhang, L.-P., Yang, H.-M. and Lian, S. (2019) Cortisol excess-mediated mitochondrial damage induced hippocampal neuronal apoptosis in mice following cold exposure. Cells 8, 612. https://doi.org/10.3390/cells8060612
  91. Yoo, S. S., Kim, Y., Lee, D. W., Ham, H. J., Park, J. H., Yeo, I. J., Chang, J. Y., Yun, J., Son, D. J., Han, S. B. and Hong, J. T. (2025) Stress accelerates depressive-like behavior through increase of SPNS2 expression in Tg2576 mice. Biomol. Ther. (Seoul) 33, 417-428. https://doi.org/10.4062/biomolther.2024.200
  92. Yoo, S. S., Lee, D. W., Ham, H. J., Yeo, I. J., Chang, J. Y., Yun, J., Son, D. J., Han, S. B. and Hong, J. T. (2024) Presenilin-2 knock-in mice show severe depressive behavior via DVL3 downregulation. CNS Neurosci. Ther. 30, e14370. https://doi.org/10.1111/cns.14370
  93. Yun, W. B., Park, J. J., Kim, J. E., Sung, J. E., Lee, H. A., Lee, J. H., Bae, C. J. and Hwang, D. Y. (2016) Overexpression of N141I PS2 increases γ-secretase activity through up-regulation of Prese nilin and Pen-2 in brain mitochondria of NSE/hPS2m transgenic mice. Lab. Anim. Res. 32, 249-256. https://doi.org/10.5625/lar.2016.32.4.249
  94. Zhang, H., Jiang, X., Ma, L., Wei, W., Li, Z., Chang, S., Wen, J., Sun, J. and Li, H. (2022) Role of Aβ in Alzheimer's-related synaptic dys function. Front. Cell Dev. Biol. 10, 964075.
  95. Zhang, S., Zhang, M., Cai, F. and Song, W. (2013) Biological func tion of Presenilin and its role in AD pathogenesis. Transl. Neuro degener. 2, 15.
  96. Zhang, X., Li, Y., Xu, H. and Zhang, Y. W. (2014) The γ-secretase com plex: from structure to function. Front. Cell. Neurosci. 8, 427.